Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The United States healthcare advertising market size reached a value of almost USD 20.8 billion in the year 2020. The market is further expected to grow at a CAGR of 4.8% between 2021 and 2026 to reach a value of almost USD 26.5 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The United States healthcare advertising market is driven by the rising prescription drug advertisements. The industry for healthcare advertising in the United States has evolved substantially after the initiation of the first code of ethics, which happened in the late 1840s. This code involved the prohibition of any advertising associated with healthcare and pharmaceutical products. However, healthcare advertising is now used for the purpose of spreading awareness regarding several diseases, health issues, the availability of modern drugs, and procedures in the country. As opposed to advertising in other industries, healthcare advertising is controlled by regulations issued by the Federal Trade Commission, state consumer protection organisations, and other regulatory bodies.
Healthcare advertising is referred to as the advertisement of healthcare and pharmaceutical products to the general population, with the purpose of disseminating awareness regarding different ailments and their remedial procedures and treatment available in the market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry is segmented on the basis product type of:
Among all of these, advertisements in the pharmaceuticals (small molecule drugs) market have shown an exponential increase in the last few years.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The United States healthcare advertising market is driven by the growth opportunities offered to several pharmaceutical marketers by online direct-to-consumer drug advertising. On account of this, they have started shifting their promotional spending on digital promotions such as product web sites, online display advertising, and social media campaigns. In addition to this, Google has permitted the advertisement of prescription drugs, addiction services, HIV home tests, and clinical trial recruitment across the country, further aiding the growth of the industry.
The industry is further invigorated by the advertisement of the medications, which is done after obtaining the certification permitting the usage of relevant keywords. Moreover, many pharmaceutical companies have begun advertising through different channels like multiple synchronised communication channels to boost their consumer reach. Apart from this, the technological advancement over the years has empowered consumers to find relevant information concerning various health-related conditions and the various available treatments. On account of this, the industry is witnessing an increase and is expected to expand over the forecast period.
The report gives a detailed analysis of the following key players in the healthcare advertising market in the United States, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
|Scope of the Report||Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product Type|
|Breakup by Product Type||Pharmaceuticals (Small Molecule Drugs) Advertising Market, Biopharmaceuticals Market, Vaccines Market, Over-the-Counter Drugs Market, Others|
|Market Dynamics||SWOT, Porter's Five Forces, Key Indicators for Price and Demand|
|Competitive Landscape||Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications|
|Companies Covered||Johnson & Johnson, Pfizer Inc, Merck & Co., Inc, GlaxoSmithKline plc.,
Eli Lilly and Company, Novartis AG, Sanofi-Aventis U.S. LLC,
AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, Bristol- Myers Squibb Company, Others
|Report Price and Purchase Option||Explore our purchase options that are best suited to your resources and industry needs.|
|Delivery Format||Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 United States Healthcare Advertising Market Snapshot
7 Industry Opportunities and Challenges
7.1 What Drives the Healthcare Advertising Market in the US?
7.1.1 Digitalization and other Technological Advancements
7.1.2 Increasing Presence of Generic and Me-too Drugs
7.1.3 Government Regulations Supporting DTC Advertising
7.1.4 Launch of New Drugs
7.1.5 Increased Consumer Reach through Mobile Advertising
7.1.6 Other Key Drivers
7.2 Market Challenges
7.2.1 Trust Gap between Consumers and Advertisers
7.2.2 Strict Rules and Regulations by FDA
7.2.3 Unethical Practices
7.2.4 Macroeconomic Scenario
7.2.5 Other Challenges
8 United States Healthcare Advertising Market Analysis
8.1 Key Industry Highlights
8.2 United States Healthcare Advertising Historical Market (2018-2022)
8.3 United States Healthcare Advertising Market Forecast (2023-2028)
8.4 United States Healthcare Advertising Market by Product Type
8.4.1 Pharmaceuticals (Small Molecule Drugs) Advertising Market
220.127.116.11 Market Share
18.104.22.168 Historical Trend (2018-2022)
22.214.171.124 Forecast Trend (2023-2028)
126.96.36.199 Breakup by Advertising Channel
188.8.131.52 Advertising Spend by Key Players
8.4.2 Biopharmaceuticals Market
184.108.40.206 Market Share
220.127.116.11 Historical Trend (2018-2022)
18.104.22.168 Forecast Trend (2023-2028)
22.214.171.124 Breakup by Advertising Channel
126.96.36.199 Advertising Spend by Key Players
8.4.3 Vaccines Market
188.8.131.52 Market Share
184.108.40.206 Historical Trend (2018-2022)
220.127.116.11 Forecast Trend (2023-2028)
18.104.22.168 Breakup by Advertising Channel
22.214.171.124 Advertising Spend by Key Players
8.4.4 Over-the-Counter Drugs Market
126.96.36.199 Market Share
188.8.131.52 Historical Trend (2018-2022)
184.108.40.206 Forecast Trend (2023-2028)
220.127.116.11 Breakup by Advertising Channel
18.104.22.168 Advertising Spend by Key Players
9 Current Trends in Healthcare Advertising
9.1 Focus on Content
9.2 Rise of Multichannel Marketing
9.3 Targeting Consumers with Local Advertising
9.4 Reliance on Social Media
9.5 Surging Mobile Marketing
9.6 Consumers Becoming Researchers
9.7 Information Dispensed through Videos
9.8 Increasing Importance of Online Reviews
10 Market Dynamics
10.1 SWOT Analysis
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyers Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Market Challenges
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players’ Sales and Advertising Spend
13.3 Company Profiles
13.3.1 Johnson & Johnson Services, Inc
22.214.171.124 Company Overview
126.96.36.199 Financial Summary
188.8.131.52 Advertising Spend by Channel
184.108.40.206 Global Sales and Advertising Spend
13.3.2 Pfizer Inc
220.127.116.11 Company Overview
18.104.22.168 Financial Summary
22.214.171.124 Advertising Spend by Channel
126.96.36.199 Global Sales and Advertising Spend
13.3.3 Merck & Co., Inc
188.8.131.52 Company Overview
184.108.40.206 Financial Summary
220.127.116.11 Advertising Spend by Channel
18.104.22.168 Global Sales and Advertising Spend
13.3.4 GlaxoSmithKline plc.
22.214.171.124 Company Overview
126.96.36.199 Financial Summary
188.8.131.52 Advertising Spend by Channel
184.108.40.206 Global Sales and Advertising Spend
13.3.5 Eli Lilly and Company
220.127.116.11 Company Overview
18.104.22.168 Financial Summary
22.214.171.124 Advertising Spend by Channel
126.96.36.199 Global Sales and Advertising Spend
13.3.6 Novartis AG
188.8.131.52 Company Overview
184.108.40.206 Financial Summary
220.127.116.11 Advertising Spend by Channel
18.104.22.168 Global Sales and Advertising Spend
13.3.7 Sanofi-Aventis U.S. LLC
22.214.171.124 Company Overview
126.96.36.199 Financial Summary
188.8.131.52 Advertising Spend by Channel
184.108.40.206 Global Sales and Advertising Spend
220.127.116.11 Company Overview
18.104.22.168 Financial Summary
22.214.171.124 Advertising Spend by Channel
126.96.36.199 Global Sales and Advertising Spend
13.3.9 F. Hoffmann-La Roche Ltd
188.8.131.52 Company Overview
184.108.40.206 Financial Summary
220.127.116.11 Advertising Spend by Channel
18.104.22.168 Global Sales and Advertising Spend
13.3.10 Bayer AG
22.214.171.124 Company Overview
126.96.36.199 Financial Summary
188.8.131.52 Advertising Spend by Channel
184.108.40.206 Global Sales and Advertising Spend
13.3.11 Bristol-Myers Squibb Company
220.127.116.11 Company Overview
18.104.22.168 Financial Summary
22.214.171.124 Advertising Spend by Channel
126.96.36.199 Global Sales and Advertising Spend
14 Industry Events and Developments
List of Key Figures and Tables
1. United States Healthcare Advertising Market: Key Industry Highlights, 2018 and 2028
2. United States Healthcare Advertising Historical Market: Breakup by Product Type (USD Billion), 2018-2022
3. United States Healthcare Advertising Market Forecast: Breakup by Product Type (USD Billion), 2023-2028
4. United States Generic Drug Market Structure
In 2020, the healthcare advertising market in the United States attained a value of nearly USD 20.8 billion.
The market is projected to grow at a CAGR of 4.8% between 2021 and 2026.
The market is estimated to witness a moderate growth in the forecast period of 2023-2028 to reach about USD 26.5 billion by 2026.
The major drivers of the industry, such as rising advertisements for prescription drugs, growth opportunities offered to several pharmaceutical marketers, and the rising number of health-conscious consumers in the country, are expected to aid the market growth.
The key trends guiding the growth of the industry include the rise of multichannel marketing and targeting consumers with local advertising.
Pharmaceuticals (small molecule drugs) advertising market is the dominant product type in the industry.
The major players in the industry are Johnson & Johnson, Pfizer Inc, Merck & Co., Inc, GlaxoSmithKline plc., Eli Lilly and Company, Novartis AG, Sanofi-Aventis U.S. LLC, AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, and Bristol- Myers Squibb Company, among others.
The United States healthcare advertising market attained a value of USD 20.8 billion in 2020, driven by the rising advertisements of prescription drugs. Aided by the rise of multichannel marketing, the industry is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 4.8%. The healthcare advertising market in the United States is projected to reach USD 26.5 billion by 2026.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its types, the pharmaceuticals (small molecule drugs) advertising market accounts for the leading share in the industry. The key players in the above industry include Johnson & Johnson, Pfizer Inc, Merck & Co., Inc, GlaxoSmithKline plc., Eli Lilly and Company, Novartis AG, Sanofi-Aventis U.S. LLC, AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, Bristol- Myers Squibb Company, and others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with industry insights that are accurate, actionable, and help them remain ahead of their competition.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.